Evidence map›Paper›PMID 25261884›Full record

Trial reportSchizophrenia research2014

Treatment response to the RENEW weight loss intervention in schizophrenia: impact of intervention setting.

Catana Brown, Jeannine Goetz, Edna Hamera, Byron Gajewski

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Schizophrenia research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Non-pharmacologicaL InterVEntions for Antipsychotic-Induced Weight Gain (RESOLVE) in People Living With Severe Mental Illness: A Realist Synthesis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Catana BrownMidwestern University, College of Health Sciences, Glendale, United States. Electronic address: cbrown2@midwestern.edu.
Jeannine GoetzUniversity of Kansas, School of Allied Health, United States.
Edna HameraUniversity of Kansas, School of Nursing, United States.
Byron GajewskiUniversity of Kansas, School of Allied Health, United States.

Funding

A Psychiatric Rehabilitation Approach to Weight LossR34MH077282 · NIMH · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAMERA, EDNA K · 2007 to 2009
$615k
NIMH NIH HHS R34 MH077282
6 · The paper itself

Abstract

backgroundIndividuals with serious mental illness have high rates of obesity and a need for specialized weight loss intervention programs. This study examines the efficacy of the RENEW weight loss intervention and examines the impact of the intervention setting on outcomes.

method136 individuals with serious mental illness from 4 different settings were randomly assigned to receive the RENEW weight loss intervention or a control condition of treatment as usual. The RENEW intervention is a one year program that includes an intensive, maintenance and intermittent supports phase.

resultsThe intervention group experienced a modest weight loss of 4.8 lbs at 3 months, 4.1 lbs at 6 months and a slight weight gain of 1.5 lbs at 12 months. The control group gained a total of 6.2 lbs at 12 months. However when settings were examined separately the responder sites had a weight loss of 9.4 lbs at 3 months, 10.9 lbs at 6 months and 7 lbs at 12 months. DISCUSSION: These results suggest that the settings in which individuals receive services may act as a support or hindrance toward response to weight loss interventions. The concept of the obesogenic environment deserves further examination as a factor in the success of weight loss programs.

Indexed as

AdultAntipsychotic AgentsFemaleHumansMaleMiddle AgedObesitySchizophreniaTreatment OutcomeWeight LossWeight Reduction ProgramsAntipsychotic AgentsInterventionObesitySchizophreniaWeight loss

Identifiers

PMID25261884
PMCPMC4253565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.